Global Medical Robots Market Latest Update’s Report 2022

Posted by sandeep gade on November 29th, 2022

 The global medical robots market is expected to reach a valuation of US$ 40 Bn by 2032 from US$ 8.1 Bn in 2022, rising at a steady CAGR of 17.4% throughout the forecast period.

Medical robotic trends, the benefits of robotic-assisted surgery, and robot-assisted rehabilitation treatment training are just some of the causes driving demand for medical robots.

Furthermore, the sales of medical robots are being driven by technological developments in robotic systems, improved reimbursement scenarios, higher surgical robot usage, and increased financing for medical robot research.

The key drivers driving the medical robots market growth are the rising demand for accurate and proper laparoscopic operations, as well as the rising demand for surgical treatments among the elderly and the rising number of occurrences of trauma injuries.

Furthermore, greater efficiency in performing operations such as surgery has promoted the sales of medical robots.

Sales of medical robots are being fueled by a worldwide shift away from open surgical procedures and toward minimally invasive surgical techniques.

In addition, medical robots are becoming increasingly effective at performing laparoscopic procedures, and new and improved procedure-specific robots are being introduced to the global market. As a result, during the anticipated period, demand for medical robots is likely to skyrocket.

Other advantages include fewer post-operative problems, shorter hospital stays, and cheaper surgery costs. As a result, the global medical robots market is predicted to increase gradually over the next few years.

Recent Developments in Medical Robots Market

The MAKO robotic surgery system for partial knee replacement received regulatory certification in Japan in 2020 from Stryker Corporation (US).

In 2020, Accuray (US) launched the CyberKnife S7 System, a next-generation CyberKnife platform that provides advanced precision, real-time artificial intelligence (AI)-driven motion tracking, and synchronised treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.

In 2020, Medtronic (Ireland) acquired Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modelling, and patient-specific implants.

The da Vinci Single-port Surgical System was approved by the FDA in 2019 by Intuitive Surgical (US).

Stryker Corporation (US) purchased Mobius Imaging, LLC and Cardan Robotics in 2019. (US). This acquisition boosts the company's imaging and robotics capabilities, as well as its research and development capabilities.

 Buy Full Report Now and Get Up to 20% Discount: https://www.persistencemarketresearch.com/checkout/33120